Cargando…
Altered cytoplasmic and nuclear ADP‐ribosylation levels analyzed with an improved ADP‐ribose binder are a prognostic factor in renal cell carcinoma
ADP‐ribosylation (ADPR) of proteins is catalyzed by ADP‐ribosyltransferases, which are targeted by inhibitors (i.e. poly(ADP‐ribose) polymerase inhibitors [PARPi]). Although renal cell carcinoma (RCC) cells are sensitive in vitro to PARPi, studies on the association between ADPR levels and somatic l...
Autores principales: | Schraml, Peter, Aimi, Fabio, Zoche, Martin, Aguilera‐Garcia, Domingo, Arnold, Fabian, Moch, Holger, Hottiger, Michael O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240151/ https://www.ncbi.nlm.nih.gov/pubmed/36999983 http://dx.doi.org/10.1002/cjp2.320 |
Ejemplares similares
-
Cytoplasmic ADP-ribosylation levels correlate with markers of patient outcome in distinct human cancers
por: Aimi, Fabio, et al.
Publicado: (2021) -
Engineering Af1521 improves ADP-ribose binding and identification of ADP-ribosylated proteins
por: Nowak, Kathrin, et al.
Publicado: (2020) -
Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites
por: Altmeyer, Matthias, et al.
Publicado: (2009) -
New Facets in the Regulation of Gene Expression by
ADP-Ribosylation and Poly(ADP-ribose) Polymerases
por: Ryu, Keun Woo, et al.
Publicado: (2015) -
Selective monitoring of the protein-free ADP-ribose released by ADP-ribosylation reversal enzymes
por: Kasson, Samuel, et al.
Publicado: (2021)